Navigation Links
New Breast MRI Technology Enables Enhanced Breast Cancer Detection
Date:11/30/2009

GAINESVILLE, Fla., Nov. 30 /PRNewswire/ -- The launch of Invivo Corporation's ONCAD for DynaCAD marks the availability of the first FDA-cleared, fully-automated morphological system for the detection and analysis by a radiologist of suspicious breast lesions. The ONCAD system will be officially unveiled at the Radiological Society of North America 2009 Annual Meeting in Chicago.

Developed in partnership with leading experts in breast MRI, ONCAD for DynaCAD uses a patented mathematical algorithm to analyze the entire breast and draw a physician's attention to abnormal morphology during a contrast-enhanced breast MRI. ONCAD's fractal mathematics and proprietary algorithms not only enhance the detection of both invasive and noninvasive lesions, the approach also delineates the extent of the disease by measuring margin sharpness to determine the degree of lesion vascularization. The suspicious lesions are marked with a color overlay, light pink for moderate suspicion and dark pink for highly suspicious lesions, an important data point in a physician's assessment.

Studies have shown that while breast MRI procedures are cost-effective screening methods for high-risk patients and have a higher sensitivity than mammography, the numerous images generated have low specificity. ONCAD provides physicians with an objective quantification of the margins of suspicious lesions by employing shape- and texture-based filters to improve specificity. The results are seamlessly integrated in an automated DynaCAD hanging. Because ONCAD provides physicians with more visual information, they are able to detect suspicious lesions that may be imperceptible to the human eye, thereby improving their diagnostic confidence.

An Era of Innovation

The introduction of ONCAD for DynaCAD is one of several advanced clinical solutions recently brought to market by Invivo Corporation. Early this year, Invivo unveiled their DynaCAD for Prostate solution, combining new analysis and interventional options for patients with elevated or rising PSA levels and negative TRUS-guided biopsy results. DynaCAD for Prostate provides the physician with a comprehensive, customizable set of visualization tools for performing realtime analysis of prostate MRI studies. DynaCAD for Prostate and DynaTRIM then enable a physician to conduct targeted MRI interventions of suspicious areas within the prostate gland, reducing the number of cores acquired during biopsy. Compared to published cancer yield rates of up to 15% with third TRUS-guided biopsies, DynaCAD for Prostate produces a 59% detection rate with a maximum of 4 MRI-guided biopsy cores.

In 2009, Invivo Corporation announced the release of three new technologies: their Luminescence Breast Coil System, DynaCAD version 2.1 with QuickClick Segmentation, and DynaSuite Neuro Advanced MR Workstation.

  • Having been an industry leader in the development of MR breast coils, Invivo designed the Luminescence Breast Coil System, a modular diagnostic and interventional coil set that delivers improved image uniformity and performance and superior signal to noise ratio. The 16-channel system answers the demand for the best quality images, best ease of use and best patient experience as breast MRI procedures increase for screening high-risk populations.
  • DynaCAD version 2.1 with QuickClick Segmentation was previewed at the RSNA Annual Meeting in 2008. The software platform maintains the core functionalities that built DynaCAD's reputation for speed, power and flexibility and features quantification tools, rendering, and BI-RADS® Reporting, making it easier for a physician to read MRI studies and generate reports. QuickClick Segmentation offers a visualization system with automated site-specific measurements, snapshots and finding reports while maintaining the ability for a physician to customize their reading and reporting style.
  • DynaSuite Neuro Advanced MR Workstation is a high performance solution for the rapid and repeatable interpretation of MR Neuro images. The solution is capable of integrating anatomical, fMRI, and 3D vascular imaging with basic analysis to produce a dynamic, 3D model within the SmartFusion(TM) review.

About Invivo Corporation

Invivo Corporation has an over 20-year history as the pioneer of progressive MRI coils, advanced clinical visualization systems, and innovative MRI-compatible interventional devices. Invivo successfully designs, manufactures and markets high-value-added medical instruments that enhance MR image quality, improving physicians' diagnostic confidence and patients' imaging experience.

SOURCE Invivo Corporation


'/>"/>
SOURCE Invivo Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... Many families have ... many long-term care insurance companies have a waiver for care if the client has ... period, when the family pays for care, is often waived, so the benefits from ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are ... cessation in breathing. Oral appliances can offer significant relief to about 75 percent ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
(Date:10/12/2017)... ... 2017 , ... On Saturday, October 21, the Health & Wellness Center at ... raise money for the American Heart Association Heart Walk. Teams of up to 10 ... to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile ... the struggle to reverse the tide of prescription drug addiction. ... regulating their medicine intake and stepping down their dosage in ... to launch in December 2017; the first 100,000 people to ... more at http://www.rebound-solution.com/ ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
Breaking Medicine Technology: